These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
165 related articles for article (PubMed ID: 7961885)
21. Identification of insulin domains important for binding to and degradation by endosomal acidic insulinase. Authier F; Danielsen GM; Kouach M; Briand G; Chauvet G Endocrinology; 2001 Jan; 142(1):276-89. PubMed ID: 11145591 [TBL] [Abstract][Full Text] [Related]
22. Localization of the insulin-binding site to the cysteine-rich region of the insulin receptor alpha-subunit. Yip CC; Hsu H; Patel RG; Hawley DM; Maddux BA; Goldfine ID Biochem Biophys Res Commun; 1988 Nov; 157(1):321-9. PubMed ID: 3058126 [TBL] [Abstract][Full Text] [Related]
23. Design and synthesis of a novel biotinylated photoreactive insulin for receptor analysis. Fabry M; Brandenburg D Biol Chem Hoppe Seyler; 1992 Mar; 373(3):143-50. PubMed ID: 1586454 [TBL] [Abstract][Full Text] [Related]
24. Identification and characterization of the ligand-binding domain of insulin receptor by use of an anti-peptide antiserum against amino acid sequence 241-251 of the alpha subunit. Yip CC; Grunfeld C; Goldfine ID Biochemistry; 1991 Jan; 30(3):695-701. PubMed ID: 1988056 [TBL] [Abstract][Full Text] [Related]
25. Expression and characterization of a 70-kDa fragment of the insulin receptor that binds insulin. Minimizing ligand binding domain of the insulin receptor. Kristensen C; Wiberg FC; Schäffer L; Andersen AS J Biol Chem; 1998 Jul; 273(28):17780-6. PubMed ID: 9651379 [TBL] [Abstract][Full Text] [Related]
26. Enhanced insulin-induced mitogenesis and mitogen-activated protein kinase activities in mutant insulin receptors with substitution of two COOH-terminal tyrosine autophosphorylation sites by phenylalanine. Ando A; Momomura K; Tobe K; Yamamoto-Honda R; Sakura H; Tamori Y; Kaburagi Y; Koshio O; Akanuma Y; Yazaki Y J Biol Chem; 1992 Jun; 267(18):12788-96. PubMed ID: 1618780 [TBL] [Abstract][Full Text] [Related]
27. Role of the COOH-terminal B-chain domain in insulin-receptor interactions. Identification of perturbations involving the insulin mainchain. Nakagawa SH; Tager HS J Biol Chem; 1987 Sep; 262(25):12054-8. PubMed ID: 3305501 [TBL] [Abstract][Full Text] [Related]
28. Extending Halogen-based Medicinal Chemistry to Proteins: IODO-INSULIN AS A CASE STUDY. El Hage K; Pandyarajan V; Phillips NB; Smith BJ; Menting JG; Whittaker J; Lawrence MC; Meuwly M; Weiss MA J Biol Chem; 2016 Dec; 291(53):27023-27041. PubMed ID: 27875310 [TBL] [Abstract][Full Text] [Related]
30. Comparison of the functional insulin binding epitopes of the A and B isoforms of the insulin receptor. Whittaker J; Sørensen H; Gadsbøll VL; Hinrichsen J J Biol Chem; 2002 Dec; 277(49):47380-4. PubMed ID: 12270939 [TBL] [Abstract][Full Text] [Related]
31. The subunit structure of the high affinity insulin receptor. Evidence for a disulfide-linked receptor complex in fat cell and liver plasma membranes. Pilch PF; Czech MP J Biol Chem; 1980 Feb; 255(4):1722-31. PubMed ID: 6986378 [TBL] [Abstract][Full Text] [Related]
32. Identification of a ligand binding site in the human neutrophil formyl peptide receptor using a site-specific fluorescent photoaffinity label and mass spectrometry. Mills JS; Miettinen HM; Barnidge D; Vlases MJ; Wimer-Mackin S; Dratz EA; Sunner J; Jesaitis AJ J Biol Chem; 1998 Apr; 273(17):10428-35. PubMed ID: 9553101 [TBL] [Abstract][Full Text] [Related]
33. Solution structure of the superactive monomeric des-[Phe(B25)] human insulin mutant: elucidation of the structural basis for the monomerization of des-[Phe(B25)] insulin and the dimerization of native insulin. Jørgensen AM; Olsen HB; Balschmidt P; Led JJ J Mol Biol; 1996 Apr; 257(3):684-99. PubMed ID: 8648633 [TBL] [Abstract][Full Text] [Related]
34. Structure of monomeric porcine DesB1-B2 despentapeptide (B26-B30) insulin at 1.65 A resolution. Diao JS; Wan ZL; Chang WR; Liang DC Acta Crystallogr D Biol Crystallogr; 1997 Sep; 53(Pt 5):507-12. PubMed ID: 15299880 [TBL] [Abstract][Full Text] [Related]
35. Characterization of an insulin receptor mutant lacking the subunit processing site. Williams JF; McClain DA; Dull TJ; Ullrich A; Olefsky JM J Biol Chem; 1990 May; 265(15):8463-9. PubMed ID: 2187866 [TBL] [Abstract][Full Text] [Related]
36. Differential docking of high-affinity peptide ligands to type A and B cholecystokinin receptors demonstrated by photoaffinity labeling. Dong M; Liu G; Pinon DI; Miller LJ Biochemistry; 2005 May; 44(17):6693-700. PubMed ID: 15850403 [TBL] [Abstract][Full Text] [Related]
37. Hormone binding site of the insulin receptor: analysis using photoaffinity-mediated avidin complexing. Wedekind F; Baer-Pontzen K; Bala-Mohan S; Choli D; Zahn H; Brandenburg D Biol Chem Hoppe Seyler; 1989 Mar; 370(3):251-8. PubMed ID: 2540769 [TBL] [Abstract][Full Text] [Related]
38. Insulin receptors in isolated human adipocytes. Characterization by photoaffinity labeling and evidence for internalization and cellular processing. Berhanu P; Kolterman OG; Baron A; Tsai P; Olefsky JM; Brandenburg D J Clin Invest; 1983 Dec; 72(6):1958-70. PubMed ID: 6358259 [TBL] [Abstract][Full Text] [Related]
39. Alanine-scanning mutagenesis of a C-terminal ligand binding domain of the insulin receptor alpha subunit. Mynarcik DC; Yu GQ; Whittaker J J Biol Chem; 1996 Feb; 271(5):2439-42. PubMed ID: 8576204 [TBL] [Abstract][Full Text] [Related]
40. An insulin receptor mutant (Asp707 --> Ala), involved in leprechaunism, is processed and transported to the cell surface but unable to bind insulin. Hart LM; Lindhout D; Van der Zon GC; Kayserilli H; Apak MY; Kleijer WJ; Van der Vorm ER; Maassen JA J Biol Chem; 1996 Aug; 271(31):18719-24. PubMed ID: 8702527 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]